SITAGLIPTIN AND VILDAGLIPTIN EFFICACY ON CARBOHYDRATE AND LIPID METABOLISM IN ELDERLY PATIENTS WITH TYPE 2 DIABETES

  • Floriana Elvira Ionică
  • Rigas F. Nikolaos
  • Florica Popescu
Keywords: type 2 diabetes, DPP-4 inhibitors, sitagliptin, vildagliptin

Abstract

Background and Aims: For many patients with type 2 diabetes (T2DM) classic oral anti-diabetic treatment is not effective and patients don’t meet the currently recommended therapeutic goals. The aim of our study was to evaluate the efficacy of dipeptydil peptidase 4 (DPP-4) inhibitors as add-on therapy to oral antidiabetics in reducing HbA1c in elderly patients with poorly controlled T2DM. Material and methods: The study included 75 elderly patients with poorly controlled T2DM, treated with known oral antihyperglycemic agents. DPP-4 inhibitors were added to current oral treatment and patients were followed for 12 months, evaluating clinical and biological parameters at baseline and after 3 months, 6 months and 12 months of therapy. Results: After the first 3 months of treatment with DPP-4 inhibitors, fasting glucose (mg/dl) decreased from 148.27 ± 44.68 to 128.94 ± 22.71, and HbA1c (%) from 7.40 ± 1.39 to 6.93 ± 0.78. Values of these two parameters continued to decline until month 12 of follow-up, but to a lesser extent, up to mean fasting glucose (mg/dl) of 127.58 ± 20.91 and HbA1c (%) of 6.72 ± 0.52. Conclusion: Glycemic profile was significantly improved after 12 months of DPP-4 treatment, with a significant decrease of HbA1c.

Published
2013-03-15
How to Cite
Ionică, Floriana, Rigas Nikolaos, and Florica Popescu. 2013. “SITAGLIPTIN AND VILDAGLIPTIN EFFICACY ON CARBOHYDRATE AND LIPID METABOLISM IN ELDERLY PATIENTS WITH TYPE 2 DIABETES”. Romanian Journal of Diabetes Nutrition and Metabolic Diseases 20 (1), 55-62. https://rjdnmd.org/index.php/RJDNMD/article/view/244.
Section
Original Research Articles